When Serena Williams told NBC’s “TODAY” show, “I just couldn’t get my weight to where I needed to be at a healthy place and believe me, I don’t take shortcuts. I do everything but shortcuts,” she added her voice to the growing list of public figures discussing the use of medications that control blood sugar and reduce appetite, such as Ozempic, Wegovy and Mounjaro.

Williams said she has lost 31 pounds since beginning the medication in 2023 and launched a campaign with telehealth company Ro to reduce stigma around the drugs. Across the United States, the demand for these drugs has surged.

A 2024 Gallup survey found that 6% of U.S. adults — about 15.5 million people — report having used injectable diabetes medicines for weight loss, including 3% currently using them. FAIR Health estimates

See Full Page